• Home
  • News
  • Analysis
  •  
    Regions
    • Australasia
    • Southeast Asia
    • Greater China
    • North Asia
    • South Asia
    • North America
    • Europe
    • Central Asia
    • MENA
  •  
    Funds
    • LPs
    • Buyout
    • Growth
    • Venture
    • Renminbi
    • Secondary
    • Credit/Special Situations
    • Infrastructure
    • Real Estate
  •  
    Investments
    • Buyout
    • Growth
    • Early stage
    • PIPE
    • Credit
  •  
    Exits
    • IPO
    • Open market
    • Trade sale
    • Buyback
  •  
    Sectors
    • Consumer
    • Financials
    • Healthcare
    • Industrials
    • Infrastructure
    • Media
    • Technology
    • Real Estate
  • Events
  • Chinese edition
  • Data & Research
  • Weekly Digest
  • Newsletters
  • Sign in
  • Events
  • Sign in
    • You are currently accessing unquote.com via your Enterprise account.

      If you already have an account please use the link below to sign in.

      If you have any problems with your access or would like to request an individual access account please contact our customer service team.

      Phone: +44 (0)870 240 8859

      Email: customerservices@incisivemedia.com

      • Sign in
     
      • Saved articles
      • Newsletters
      • Account details
      • Contact support
      • Sign out
     
  • Follow us
    • RSS
    • Twitter
    • LinkedIn
    • Newsletters
  • Free Trial
  • Subscribe
  • Weekly Digest
  • Chinese edition
  • Data & Research
    • Latest Data & Research
      2023-china-216x305
      Regional Reports

      The reports review the year's local private equity and venture capital activity and are filled with up-to-date data and intelligence on fundraising, investments, exits and M&A. The regional reports also feature information on key companies.

      Read more
      2016-pevc-cover
      Industry Review

      Asian Private Equity and Venture Capital Review provides an independent overview of the private equity, venture capital and M&A activities in the Asia region. It delivers insights on investments made, capital raised, sector specific figures and more.

      Read more
      AVCJ Database

      AVCJ Database is the ultimate link between Asian dealmakers and those who provide advisory, financial, legal and technological services to the private equity, venture capital and M&A industries. It is packed with facts and figures on more than 153,000 companies and almost 117,000 transactions.

      Read more
AVCJ
AVCJ
  • Home
  • News
  • Analysis
  • Regions
  • Funds
  • Investments
  • Exits
  • Sectors
  • You are currently accessing unquote.com via your Enterprise account.

    If you already have an account please use the link below to sign in.

    If you have any problems with your access or would like to request an individual access account please contact our customer service team.

    Phone: +44 (0)870 240 8859

    Email: customerservices@incisivemedia.com

    • Sign in
 
    • Saved articles
    • Newsletters
    • Account details
    • Contact support
    • Sign out
 

Larissa Ku

Follow Larissa Ku

  • Article feed

Articles by Larissa Ku

5Y raises $2b across dollar, renminbi funds

China's 5Y Capital has raised nearly $2 billion for its latest US dollar and renminbi-denominated funds, securing $1.7 billion for the US dollar pool and around RMB1.9 billion ($290 million) for the local currency vehicle.

  • Greater China
  • 13 April 2021
PE-backed property platform Anjuke to go public in Hong Kong
PE-backed property platform Anjuke to go public in Hong Kong

Anjuke, a Chinese online property marketplace controlled by classifieds player 58.com, has filed for a Hong Kong listing. It follows a $250 million pre-IPO funding round featuring two Hong Kong property developers.

  • Greater China
  • 12 April 2021
China mRNA vaccine provider Abogen raises $92m

Suzhou Abogen Biosciences, a Chinese mRNA vaccine provider, has raised RMB600 million ($92 million) led by PICC Capital - an investment unit under People’s Insurance Company of China - and state-backed SDIC Venture Capital.

  • Greater China
  • 09 April 2021
China's Danke to be delisted in US

The New York Exchange is set to delist Chinese apartment rental service provider Danke, having halted trading in the stock on March 15 because of poor information disclosure.

  • Greater China
  • 08 April 2021
Long Hill raises $300m for third China VC fund

Long Hill Capital closed its third US dollar-denominated fund at $300 million with a remit to pursue healthcare and longevity-related opportunities, which includes start-ups focused on wellness and services aimed at aging consumers.

  • Greater China
  • 08 April 2021
China grocery platform Dingdong Maicai raises $700m

DST Global and Coatue Management have led a $700 million Series D for China-based online fresh produce delivery business Dingdong Maicai. Existing investors including CMC Group re-upped.

  • Greater China
  • 08 April 2021
Alibaba, DST lead Series D for China's Nice Tuan

Alibaba Group and DST Global have led a $750 million Series D round for Shihuituan, a China-based community group buying platform also known as Nice Tuan.

  • Greater China
  • 31 March 2021
China consumer brands Genki Forest, Tasogare secure funding
China consumer brands Genki Forest, Tasogare secure funding

Two emerging Chinese beverage brands - Genki Forest and Tasogare, which focus on sparkling water and coffee, respectively - have completed new funding rounds.

  • Greater China
  • 31 March 2021
China chip designer Biren gets $410m Series B
China chip designer Biren gets $410m Series B

Biren Technology, a Chinese chip design company, has raised a RMB2.7 billion ($410 million) Series B round led by Ping An Insurance, New World Development, and Country Garden Venture Capital.

  • Greater China
  • 31 March 2021
Portfolio: GL Capital & SciClone Pharmaceuticals

GL Capital has helped China’s SciClone Pharmaceuticals position itself for the future while continuing to monetize its key legacy drug. A Hong Kong listing was the reward

  • Greater China
  • 30 March 2021
Matrix leads Series E tranche for China corporate training platform

Matrix Partners China has led a second tranche of Series E funding - worth $90 million - for Yunxuetang, a Chinese online corporate training services provider.

  • Expansion
  • 30 March 2021
Redpoint China promotes Kyle Liu to partner
Redpoint China promotes Kyle Liu to partner

Redpoint China Ventures has promoted Kyle Liu, who focuses on early-stage enterprise services and cutting-edge technology investments, to partner level.

  • Greater China
  • 30 March 2021
KKR joins $200m round for China coding education start-up

Hetao 101, a Chinese online education platform that provides computer programming courses for children, has raised $200 million in Series C funding led by KKR, Vision Plus Capital, and GL Ventures.

  • Greater China
  • 29 March 2021
China's Baidu raises funding for chip unit at $2b valuation
China's Baidu raises funding for chip unit at $2b valuation

CPE has led a funding round for Kunlun, the semiconductor unit of Chinese search giant Baidu, at a post-deal valuation of approximately RMB13 billion ($2 billion).

  • Greater China
  • 29 March 2021
China yogurt brand secures $122m Series B
China yogurt brand secures $122m Series B

Simple Love, also known as Jian’Ai, a Chinese yogurt brand, has raised RMB800 million ($122 million) in Series B funding from Matrix Partners China, BA Capital, CITIC Agriculture Fund, and Maison Capital. They all backed the company's RMB400 million Series...

  • Greater China
  • 26 March 2021
CMB, Mirae lead Series C for China biotech player EpimAb

Shanghai-based EpimAb Biotherapeutics has raised $120 million in Series C funding led by CMB International and Korea’s Mirae Asset Financial Group.

  • Greater China
  • 25 March 2021
China drug development outsourcer raises $70m
China drug development outsourcer raises $70m

Zhenge Biotech – a Shanghai-based contract development and manufacturing organization (CDMO) for large molecule drugs – has raised $70 million in Series B funding led by Qiming Venture Partners and IDG Capital.

  • Early-stage
  • 25 March 2021
China's Taishan Beer raises $92m
China's Taishan Beer raises $92m

CMC Capital Group has committed RMB600 million ($92 million) in funding to Chinese domestic beer brand Taishan.

  • Greater China
  • 24 March 2021
China direct lending: Creative credit

A combination of improved collateral, rising yields and robust demand is drawing investors to China’s direct lending space. Opportunities abound, but local execution remains critical

  • Greater China
  • 23 March 2021
Bain backs China gas station platform Newlink

Bain Capital Private Equity led a $200 million investment in Newlink Group, operator of a platform that helps drivers in China locate the best value gas stations and charging piles. Joy Capital re-upped in the round.

  • Greater China
  • 23 March 2021
China cybersecurity player ThreatBook raises $77m
China cybersecurity player ThreatBook raises $77m

Beijing-based cybersecurity solutions provider ThreatBook has completed a RMB500 million ($77 million) Series E round led by CPE and featuring existing investor V Fund.

  • Greater China
  • 22 March 2021
China's GSR Ventures appoints first female managing director
China's GSR Ventures appoints first female managing director

Yutong Zhang has become the first woman to join the team of managing directors that leads Chinse VC firm GSR Ventures.

  • Greater China
  • 19 March 2021
China's B2B trading platform Ichunt raises $100m
China's B2B trading platform Ichunt raises $100m

Ichunt.com, a Chinese B2B trading platform for electronic components, has raised nearly $100 million in Series C funding from JD MRO, the industrial supplies business of local e-commerce giant JD.com.

  • Greater China
  • 18 March 2021
CMB, Tiantu lead $300m Series D for China's Guoquan

Guoquan, a Chinese hot pot ingredients supplier, has raised a $300 million Series D round led by CMB International and Tiantu Capital.

  • Greater China
  • 18 March 2021
282930
  • About AVCJ
  • Advertise
  • Contacts
  • About ION Analytics
  • Terms of use
  • Privacy policy
  • Group disclaimer
  • RSS
  • Twitter
  • LinkedIn
  • Newsletters

© Merger Market

© Mergermarket Limited, 10 Queen Street Place, London EC4R 1BE - Company registration number 03879547

Digital publisher of the year 2010 & 2013

Digital publisher of the year 2010 & 2013